Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
KATP Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation.
[Vitamin D and neurology.]
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
A pilot study of a telehealth intervention for persons with spinal cord dysfunction.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Interactions between microglia and T cells in multiple sclerosis pathobiology.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Telemedicine for Monitoring MS Activity and Progression.
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis.
Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
MS as a gateway disease.
Corticosteroid-responsive torticollis as a presenting symptom of multiple sclerosis.
GABA transport and neuroinflammation are coupled in multiple sclerosis: Regulation of the GABA transporter-2 by ganaxolone.
The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
Improved MRI quantification of spinal cord atrophy in multiple sclerosis.
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Exercise in the management of persons with multiple sclerosis.
Pages
« first
‹ previous
…
370
371
372
373
374
375
376
377
378
…
next ›
last »